- PR Newswire•19 hours ago
SANTA BARBARA, Calif. and INDIANAPOLIS, March 23, 2017 /PRNewswire/ -- Eli Lilly and Company (LLY) and the William Sansum Diabetes Center have established a research collaboration to improve the lives of Latino people affected by diabetes through enhanced research, education and care.
- Investopedia•2 days ago
Novartis’ RLX030 (serelaxin) failed to meet both the primary endpoints of the trial in treating patients with acute heart failure
- Accesswire•2 days ago
Upcoming AWS Coverage on AbbVie LONDON, UK / ACCESSWIRE / March 22, 2017 / Active Wall St. blog coverage looks at the headline from US drugmaker Eli Lilly and Co. (NYSE: LLY ) as the Company announced ...
LLY : Summary for Eli Lilly and Company Common St - Yahoo Finance
Eli Lilly and Company (LLY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||83.92 - 85.05|
|52 Week Range||64.18 - 86.14|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||32.72|
|Dividend & Yield||2.08 (2.47%)|
|1y Target Est||N/A|